Sarepta Therapeutics Inc (SRPT) (Q2 2026) Earnings Call Highlights: Strong Profitability and ...

Yahoo Finance · Aug 6, 2026 · Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Inc (SRPT) reports Q2 2026 GAAP operating income of $13 million and advances siRNA pipeline while navigating Elevidys revenue challenges.

Original at Yahoo Finance

Not investment advice. Cached headline, not a full reprint.